77 related articles for article (PubMed ID: 38460070)
1. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
2. Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.
Drent M; Wijnen PA; Jessurun NT; Harmsze AM; Bekers O; Bast A
Drug Saf; 2024 Apr; 47(4):355-363. PubMed ID: 38460070
[TBL] [Abstract][Full Text] [Related]
3. Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers.
Jessurun NT; Wijnen PA; Bast A; van Puijenbroek EP; Bekers O; Drent M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316326
[TBL] [Abstract][Full Text] [Related]
4. Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.
Wijnen PA; Drent M; Nelemans PJ; Kuijpers PM; Koek GH; Neef C; Haenen GR; Bekers O
Drug Saf; 2008; 31(12):1125-34. PubMed ID: 19026029
[TBL] [Abstract][Full Text] [Related]
5. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.
Jessurun NT; Drent M; van Puijenbroek EP; Bekers O; Wijnen PA; Bast A
Curr Opin Pulm Med; 2019 Sep; 25(5):468-477. PubMed ID: 31365381
[TBL] [Abstract][Full Text] [Related]
7. Use of Next-Generation Sequencing to Support the Diagnosis of Familial Interstitial Pneumonia.
Gigante AR; Tinoco EM; Fonseca A; Marques I; Sanches A; Salgueiro N; Nogueira C; Campainha S; Neves S
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833253
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial.
Vos CF; Ter Hark SE; Schellekens AFA; Spijker J; van der Meij A; Grotenhuis AJ; Mihaescu R; Kievit W; Donders R; Aarnoutse RE; Coenen MJH; Janzing JGE
JAMA Netw Open; 2023 May; 6(5):e2312443. PubMed ID: 37155164
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Interstitial Lung Diseases.
Ng N; Padilla ML; Camus P
Immunol Allergy Clin North Am; 2023 May; 43(2):341-357. PubMed ID: 37055092
[TBL] [Abstract][Full Text] [Related]
10. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
[TBL] [Abstract][Full Text] [Related]
11. Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.
Yong WP; Teo FS; Teo LL; Ng MC; Tan TJ; Low SY; Wong K; Ang P; Choo SP; Lee KH; Lee SC
Expert Opin Drug Metab Toxicol; 2022 Dec; 18(12):805-815. PubMed ID: 36636012
[TBL] [Abstract][Full Text] [Related]
12. The Safety of Inpatient Health Care.
Bates DW; Levine DM; Salmasian H; Syrowatka A; Shahian DM; Lipsitz S; Zebrowski JP; Myers LC; Logan MS; Roy CG; Iannaccone C; Frits ML; Volk LA; Dulgarian S; Amato MG; Edrees HH; Sato L; Folcarelli P; Einbinder JS; Reynolds ME; Mort E
N Engl J Med; 2023 Jan; 388(2):142-153. PubMed ID: 36630622
[TBL] [Abstract][Full Text] [Related]
13. Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK; Cottin V; Dhar R; Danoff S; Flaherty KR; Brown KK; Mohan A; Renzoni E; Mohan M; Udwadia Z; Shenoy P; Currow D; Devraj A; Jankharia B; Kulshrestha R; Jones S; Ravaglia C; Quadrelli S; Iyer R; Dhooria S; Kolb M; Wells AU
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36517177
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung diseases.
Wijsenbeek M; Suzuki A; Maher TM
Lancet; 2022 Sep; 400(10354):769-786. PubMed ID: 35964592
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
